Form D · Other Technology
ClearLight Biotechnologies, LLC
Sunnyvale, CA · CIK 0001656367
Offering snapshot reported Dec 14, 2018 · SEC filing
- Reported sold
- $2.77M Offering amount: $3.16M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $1.5M Reported outside-investor minimum
- First sale
- Feb 2, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 14, 2018 | Initial | $2,767,341 | No comparison | 3 | SEC filing |
| Jan 18, 2017 | Initial | $3,499,999 | No comparison | 2 | SEC filing |
| Oct 22, 2015 | Initial | $2,576,754 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-327931
Offering closed March 20, 2018.
Source: Form D, filed Dec 14, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karl Deisseroth | Director |
| Laurie Goodman | Executive |
| Albert Hansen | Director |
| Sarah Mc Curdy | Director, Executive |
| John Snyder | Director |
| Alex Wiegers | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
428 Oakmead Parkway
Sunnyvale, CA, 94085
Sunnyvale, CA, 94085